We are live on ! Find out more
CAU

Caxton Associates (UK) Portfolio holdings

AUM $4.42B
1-Year Est. Return 49.83%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+49.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.11B
AUM Growth
+$874M
Cap. Flow
+$742M
Cap. Flow %
14.53%
Top 10 Hldgs %
58.16%
Holding
1,006
New
332
Increased
193
Reduced
186
Closed
254

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$495M
2
TSLA icon
Tesla
TSLA
+$393M
3
BP icon
BP
BP
+$365M
4
B
Barrick Mining
B
+$225M
5
AVGO icon
Broadcom
AVGO
+$175M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$516M
2
MSFT icon
Microsoft
MSFT
+$252M
3
INTC icon
Intel
INTC
+$128M
4
AMZN icon
Amazon
AMZN
+$123M
5
K
Kellanova
K
+$43.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.75%
2 Technology 27.07%
3 Energy 11.08%
4 Materials 8.27%
5 Healthcare 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
Z icon
676
Zillow
Z
$7.71B
$238K ﹤0.01%
3,484
-96,516
-97% -$6.99M
UTZ icon
677
Utz Brands
UTZ
$1.25B
$238K ﹤0.01%
+22,894
New +$247K
NGVT icon
678
Ingevity
NGVT
$2.44B
$237K ﹤0.01%
+3,999
New +$217K
GTN icon
679
Gray Television
GTN
$417M
$233K ﹤0.01%
48,044
-235,689
-83% -$1.15M
FIVN icon
680
FIVE9
FIVN
$2.12B
$232K ﹤0.01%
+11,565
New +$245K
AMN icon
681
AMN Healthcare
AMN
$1.35B
$231K ﹤0.01%
+14,660
New +$262K
BCO icon
682
Brink's
BCO
$4.84B
$230K ﹤0.01%
+1,973
New +$226K
SLNO
683
DELISTED
Soleno Therapeutics
SLNO
$230K ﹤0.01%
+4,959
New +$272K
CTKB icon
684
Cytek Biosciences
CTKB
$557M
$229K ﹤0.01%
45,376
-48,032
-51% -$223K
AES icon
685
AES
AES
$10.6B
$227K ﹤0.01%
15,830
+1,464
+10% +$20.6K
HD icon
686
Home Depot
HD
$332B
$226K ﹤0.01%
+658
New +$241K
NDSN icon
687
Nordson
NDSN
$16.4B
$225K ﹤0.01%
935
-3,166
-77% -$744K
APEI icon
688
American Public Education
APEI
$910M
$225K ﹤0.01%
5,943
-5,375
-47% -$192K
BWMN icon
689
Bowman Consulting
BWMN
$453M
$224K ﹤0.01%
6,798
PACS icon
690
PACS Group
PACS
$7.44B
$223K ﹤0.01%
+5,813
New +$128K
SNAP icon
691
Snap
SNAP
$7.89B
$223K ﹤0.01%
27,624
+16,789
+155% +$133K
SHOO icon
692
Steven Madden
SHOO
$3.5B
$223K ﹤0.01%
+5,353
New +$207K
NBTB icon
693
NBT Bancorp
NBTB
$2.75B
$222K ﹤0.01%
+5,358
New +$223K
IR icon
694
Ingersoll Rand
IR
$33B
$222K ﹤0.01%
+2,799
New +$221K
NABL icon
695
N-able
NABL
$821M
$222K ﹤0.01%
+29,619
New +$226K
FWONK icon
696
Liberty Media Series C
FWONK
$25.1B
$221K ﹤0.01%
+2,243
New +$220K
EVTC icon
697
Evertec
EVTC
$1.95B
$220K ﹤0.01%
+7,579
New +$225K
MCD icon
698
McDonald's
MCD
$191B
$219K ﹤0.01%
+715
New +$219K
OCUL icon
699
Ocular Therapeutix
OCUL
$1.85B
$218K ﹤0.01%
+17,932
New +$218K
GFF icon
700
Griffon
GFF
$4.03B
$217K ﹤0.01%
+2,950
New +$219K

Similar funds

Caxton Associates (UK)'s Q4 2025 Portfolio in Review

As of Q4 2025, Caxton Associates (UK) held 1,006 positions worth $5.11B, up 21% from $4.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (UK) deployed $742M of net new capital in Q4 2025, opening 332 new positions and adding to 193 existing holdings. Its largest new stake was Advanced Micro Devices: 2,205,081 shares worth $472M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Apple, an estimated $516M trimmed.

  • Caxton Associates (UK)'s largest Q4 2025 buy was Advanced Micro Devices: 2,205,081 shares worth $472M.
  • Caxton Associates (UK) added most to Tesla in Q4 2025, an estimated $393M increase.
  • Caxton Associates (UK)'s biggest Q4 2025 reduction was Apple, cutting an estimated $516M.
  • Caxton Associates (UK) fully exited Kellanova in Q4 2025, selling an estimated $43.2M.
  • Caxton Associates (UK)'s ten largest holdings make up 58% of its $5.11B portfolio in Q4 2025.
  • Caxton Associates (UK) opened 332 new positions and closed 254 in Q4 2025.
  • Caxton Associates (UK)'s portfolio value rose 21% quarter-over-quarter to $5.11B.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.